Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|July 23, 2014
Synthesis and Pharmacological Evaluation of DHβE Analogues as Neuronal Nicotinic Acetylcholine Receptor AntagonistsTue Heesgaard Jepsen, Anders A Jensen, Mads Henrik Lund, et al.Journal of Medicinal Chemistry|November 6, 2013
Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonistsFrançois Crestey, Anders A Jensen, Morten Borch, et al.Neurochemical Research|February 13, 2014
Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailabilitySebastian Leth-Petersen, Christoffer Bundgaard, Martin Hansen, et al.Journal of Pharmaceutical and Biomedical Analysis|March 30, 2021
A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brainKateryna Breusova, Kristian Goldeman Ernstsen, Mikael Palner, et al.Drug Testing and Analysis|July 13, 2016
Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOHLine Marie Nielsen, Niels Bjerre Holm, Sebastian Leth-Petersen, et al.Organic & Biomolecular Chemistry|November 4, 2005
Synthesis and binding studies of 2-arylapomorphinesKåre Søndergaard, Jesper Langgaard Kristensen, Mikael Palner, et al.Bioorganic & Medicinal Chemistry|January 14, 2015
Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonistsMartin Hansen, Stine Engesgaard Jacobsen, Shane Plunkett, et al.International Journal of Pharmaceutics|August 8, 2026
Multiple prodrug approach for topical application: flux across silicone membranes upon simultaneous administration of salicylate estersHannah Grønbech Kolberg, Adrian Gjetnes Rossebø, Margaux Civat, et al.Molecular Imaging and Biology|January 12, 2013
Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36Anders Ettrup, Søren Holm, Martin Hansen, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 2017
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor AgonistAnders A Jensen, John D McCorvy, Sebastian Leth-Petersen, et al.Pageof 3